| Bioactivity | MGAT2-IN-4 (compound 33) is an inhibitor of monoacylglycerol transferase 2 (MGAT2), with liver metabolic stability. MGAT2-IN-4 can be used for research on obesity, diabetes and non-alcoholic steatohepatitis (NASH)[1]. |
| Target | Monoacylglycerol transferase 2 (MGAT2) |
| Name | MGAT2-IN-4 |
| CAS | 1841424-92-7 |
| Formula | C27H27N5O |
| Molar Mass | 437.54 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Moore F, et al. Discovery of novel pyridinones as MGAT2 inhibitors for the treatment of metabolic disorders. Bioorg Med Chem Lett. 2023 Jul 15;91:129362. |
MGAT2-IN-4
CAS: 1841424-92-7 F: C27H27N5O W: 437.54
MGAT2-IN-4 (compound 33) is an inhibitor of monoacylglycerol transferase 2 (MGAT2), with liver metabolic stability. MGAT
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.